Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Platelet Rich Plasma as a Treatment For Resistant Corneal Ulcers

NCT05515731 is registered in ClinicalTrials.gov with Alaa Gamal as lead sponsor.

NCT NCT05515731
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05515731 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Platelet Rich Plasma as a Treatment For Resistant Corneal Ulcers
Lead sponsor
Alaa Gamal
Phase
Phase 4
Overall status
Completed
Start date
January 1, 2021
Completion date
December 31, 2021
Enrollment
14 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cornea ulcer